<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04200872</url>
  </required_header>
  <id_info>
    <org_study_id>PAAS</org_study_id>
    <nct_id>NCT04200872</nct_id>
  </id_info>
  <brief_title>Observational Retrospective Study on the Clinical and Radiographic Outcomes of the Aseptic Pseudarthrosis Treatment of the Upper Limb</brief_title>
  <official_title>Retrospective Study on the Clinical Outcomes of the Aseptic Pseudarthrosis Treatment of the Upper Limb</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to collect boh clinical and radiographic data coming from the
      treated patients for pseudarthrosis of the upper limbs from 2000 to 2017 at the SC Orthopedic
      Surgery, Innovative Techniques of the Istituto Ortopedico Rizzoli in order to evaluate the
      clinical and radiographic outcomes of the treatment, with or without the application of
      biological adjuvants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The bone healing requires the integrations of two main principles: biomechanical aspect and
      biological aspect. The second one has having growing interest.

      The use of the biological adjuvants, as growth factors (rhBMP2 and 7), platelet-derived
      growth factors (PDGFs), Platelet gel (PG) or Plasma Rich Fibrin (PRF), as well as peptides
      and molecules are demonstrating promising results in the field of bone regeneration.

      The addition of autologous bone marrow concentrate cells has proven to be an effective option
      in the treatment of bone defects, although to date there is no clear superiority of one
      method over the other.

      In light of this, the purpose of the study is to evaluate the clinical and radiographic
      outcomes of the treatment, with or without the application of biological adjuvants,
      collecting data coming from the treated patients for pseudarthrosis of the upper limbs from
      2000 to 2017 at the SC Orthopedic Surgery, Innovative Techniques of the Istituto Ortopedico
      Rizzoli
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 4, 2019</start_date>
  <completion_date type="Anticipated">May 4, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 4, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pseudoarthrosis Radiographic Healing Score (PRHS)</measure>
    <time_frame>12 months</time_frame>
    <description>Numeric score rapresenting presence or absence of bone callus. The score range from 0 to 4, with 0 score rapresent absence of bone callus and no bone graft integration, and 4 presence of bone callus and completed bone graft integration.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pseudarthrosis</condition>
  <arm_group>
    <arm_group_label>biological adjuvants</arm_group_label>
    <description>patients with aseptic pseudarthrosis clinically treated with biological adjuvants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without biological adjuvants</arm_group_label>
    <description>patients with aseptic pseudarthrosis clinically treated without biological adjuvants</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biological adjuvants</intervention_name>
    <description>patients with aseptic pseudarthrosis clinically treated with biological adjuvants</description>
    <arm_group_label>biological adjuvants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no biological adjuvants</intervention_name>
    <description>patients with aseptic pseudarthrosis clinically treated without biological adjuvants</description>
    <arm_group_label>without biological adjuvants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients surgically treated from 2000 to 2017 at the Innovative Techniques Orthopedic
        Surgery - Musculoskeletal Tissue Bank (BTM) of the Istituto Ortopedico Rizzoli for
        pseudoarthrosis of the upper limb (with or without biological adjuvants)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with post-traumatic pseudoarthrosis of the long bones of the upper limb

          -  Duration of at least 6-9 months without clinical-radiographic signs of healing in the
             3 months prior to pseudoarthroses

        Exclusion Criteria:

          -  Pseudoarthrosis due to pathological fracture

          -  Infected pseudarthrosis

          -  Pseudoarthrosis treated with external fixation

          -  BMI&gt; 35
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Istituto Ortopedico Rizzoli</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Krishnakumar GS, Roffi A, Reale D, Kon E, Filardo G. Clinical application of bone morphogenetic proteins for bone healing: a systematic review. Int Orthop. 2017 Jun;41(6):1073-1083. doi: 10.1007/s00264-017-3471-9. Epub 2017 Apr 19. Review.</citation>
    <PMID>28424852</PMID>
  </reference>
  <reference>
    <citation>Dallari D, Savarino L, Stagni C, Cenni E, Cenacchi A, Fornasari PM, Albisinni U, Rimondi E, Baldini N, Giunti A. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am. 2007 Nov;89(11):2413-20.</citation>
    <PMID>17974883</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 28, 2019</study_first_submitted>
  <study_first_submitted_qc>December 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2019</study_first_posted>
  <last_update_submitted>December 13, 2019</last_update_submitted>
  <last_update_submitted_qc>December 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pseudarthrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

